SUMMARY -We report a fi rst case of refractory several-hour sinus bradycardia, a rare but already described side eff ect of intramuscular administration of carboprost tromethamine to induce abortion for medical indication in a patient without cardiovascular and other diseases. After administration of atropine sulfate 3x0.5 mg intravenously without eff ect, the patient's sinus rhythm spontaneously normalized as carboprost was eliminated from the body (it has a 3-hour half-life). It is reasonable to believe that the specifi c prostaglandin underlay the etiology of bradycardia.
Introduction
Th e most common drugs in use for the induction of abortion and labor, as well as for curative obstetric hemorrhage are misoprostol, gemeprost, sulprostone, dinoprost and carboprost tromethamine. Th ese drugs can be used either intravenously, intramuscularly, per os, vaginally or rectally. Carboprost is a synthetic prostaglandin analogue of PGF2 that causes myometrial contractions by binding to the prostaglandin E2 receptor. Th e known side eff ects of exogenous prostaglandins are irritability, nausea, vomiting, diarrhea, coughing, dyspnea, asthma, hypertension, fl ushing, and pyrexia. Contraindications include obstructive lung disease and clinically relevant infl ammatory disease. Cardiovascular side eff ects, albeit rare, mainly occur alongside cardiovascular collapse [1] [2] [3] . We report a fi rst case of refractory several-hour sinus bradycardia, a rare but already described side eff ect of intramuscular administration of carboprost to induce abortion with medical indication.
Case Report
A 32-year-old pregnant woman was hospitalized at Department of Obstetrics because of preterm premature rupture of membranes (PPROM) with anhydramnios and intrauterine fetal death in 20 th week of gestation. Obstetric history revealed two pregnancies with two term births with normal neurocognitive development. Th e course of the current pregnancy was otherwise normal and microbiological cervical swabs were negative for pathogens. From the family history it was noted that her father had died from myocardial infarction, but her mother was healthy. Personal history was unremarkable; she works as a trader, denied drug use, and smoked 10 cigarettes per day prior to pregnancy. On admission, regular vital functions were recorded including normal temperature, pulse, and blood pressure. Laboratory tests (hematologic, coagulation, biochemical including C-reactive protein) were within the reference range. Obstetric examination evaluated patency of the cervical canal to 2 cm. Ultrasound confi rmed the initial diagnosis.
Given the fi ndings, the patient was explained the possible risks of therapy and consent was obtained for the induction of labor with a 0.25 mg intramuscular dose of the prostaglandin carboprost thromethamine (Prostin 15 M®, Pfi zer). Antibiotic prophylaxis was achieved with ampicillin intravenous 1 g/6 h. Half an hour after the fi rst injection of carboprost, the patient was cold, sweaty, weak, and felt urgent need to defecate.
With the help of a midwife, she went to the toilet but collapsed. Th e midwife could not palpate the pulse, and she lied the patient on the fl oor, put her in Trendelenburg's position, and called a doctor. Upon arrival, the doctor palpated pulse of 35/min on radial artery. Th e patient was somnolent, complaining of painless discomfort in the chest. Her vital parameters showed oxygen saturation of 90% and blood pressure of 90/50 mm Hg.
Immediate intravenous infusion of Ringer's lactate was administered, but she was still bradycardic. After 5 minutes, a 0.5 mg dose of atropine was administered intravenously, successfully raising the pulse to 50/min. Th e elevation in heart rate was only transient, as it dropped soon to 30/min. Th e patient was administered 500 mL of colloid solution (HAES) and transferred to the Intensive Care Unit (ICU). In the ICU, her blood pressure was 100/60 mm Hg and her electrocardiogram (ECG) showed sinus bradycardia of 30/min. No other abnormalities, including abnormal atrioventricular conduction, were detected on ECG. Another 0.5 mg dose of atropine was administered intravenously. Th e possible embolic events and acute coronary syndrome were excluded by laboratory analysis of D-dimer, troponin and creatine phosphokinase (MB fraction). One hour after arrival, repeat ECG still showed sinus bradycardia without any eff ect of three repeated 0.5 mg doses of intravenous atropine. Blood pressure was maintained at 110/70 mm Hg with the administration of colloids and crystalloids.
While in the ICU, the pregnant patient felt strong contractions and quickly delivered a dead embryo with the placenta en bloc. Ultrasound showed a blank empty uterine cavity and obstetric procedure ended. Prophylactic use of ampicillin was continued. Half an hour after delivery, a heart rate increase to 50/min was noted, and then to 60/min after one hour. Follow up laboratory fi ndings were normal, except for mild leukocytosis to 12.3 (the possible side eff ect of prostaglandin). With continuous monitoring, the patient had no more episodes of bradycardia or hypotension. After 24-hour continuous ECG recording and echocardiographic examination, both of which were unremarkable, she was discharged with recommendation to do clinical examination after one month. Follow up cardiologist examination performed one month later showed normal cardiac status.
Discussion
Th e eff ects of prostaglandins on the cardiovascular system are rare, but can be dramatic. Bradycardia and hypotension caused by exogenous prostaglandin was described in experimental pharmacology (e.g., on cats), and the mentioned complications were inhibited by use of meclofenamic acid 4 . Hainsworth 5 has described the possible pathophysiological mechanism of bradycardia and hypotension on endogenous bradykinin and prostaglandins due to the eff ects on chemosensitive ventricular mechanoreceptors and coronary baroreceptors. Hintze 6 has described vasoactive eff ects of prostaglandin with refl ex bradycardia and hypotension due to stimulation of cardiac receptors predominantly in the inferoposterior wall of the left ventricle.
Vagal bradycardia as an eff ect of prostaglandins due to activation of cardiac refl ex sensitivity to myocardial ischemia has been described by StaszewskaBarczak 7 . However, only a few papers describe the negative cardiovascular eff ects of prostaglandins in obstetrics. Vasospastic angina pectoris with bradycardia after induction of labor with mifepristone and gemeprost in pregnant women with migraine and smoking history has been described by Lindhardt et al. 1 . Th e authors suggest taking careful history of the possible vasospastic disease in women as the prevention of serious cardiac complications.
Two works report on cardiac arrest after administration of sulprostone. In the fi rst one, arrest occurred upon the intravenous use of sulprostone after cesarean section due to postpartum hemorrhage with successful resuscitation. Th e authors emphasize the potential impact of sulprostone on coronary spasm, bradycardia, and asystole 2 . Th e other describes cardiac arrest in a 39-year-old woman in labor after the application of sulprostone into the uterine cavity because of postpartum hemorrhage following manual removal of the placenta. Resuscitation took a long time, but was successful. Evidence in the literature suggests that sulprostone is contraindicated in women who are older than 35 years, smoke, or have other cardiovascular risk factors 3 . With the exception of smoking outside of pregnancy, our patient had no major risk factors for developing cardiovascular side eff ects. Considering that the patient's sinus rhythm spontaneously normalized as carboprost was eliminated from the body (it has a 3-hour half-life), it is reasonable to believe that the specifi c prostaglandin underlay the etiology of bradycardia.
